| URL | https://www.wbaltv.com/article/covid-19-vaccine-jo |
| Source | wbaltv.com |
| Date Published | 01/28/2021 |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | Johnson & Johnson |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2021 |
| Year reshoring implemented or to be implemented: | 2021 |
| Domestically, the work will be done: | In-house |
| City reshored to: | Baltimore |
| State(s) reshored to: | MD |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | covid-19 vaccine |
| What domestic positive factors made reshoring more attractive? | Impact on domestic economy, Under-utilized capacity, covid-19 |